Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
97
天
Targeting nucleolin-driven cancer stemness suppresses high-risk neuroblastoma in vivo
作者
Dan Qi; Ronghu Ke; Euni Wu; Yizhong Pan; S. Stephen Yi; Jason H. Huang; Erxi Wu展开收起
作者单位
Department of Neurosurgery and Neuroscience Institute, Baylor Scott & White Health, Temple, TX 76508, USA; Baylor Research Institute, Baylor Scott & White Health, Temple, TX 76508, USA; Department of Neurosurgery, Baylor College of Medicine, Temple, TX 76508, USA; Department of Electrical and Computer Engineering, Cockrell School of Engineering, The University of Texas at Austin, Austin, TX 78712, USA; Naresh K. Vashisht College of Medicine and Irma Lerma Rangel College of Pharmacy, Texas A&M University, College Station, TX 77843, USA; Cancer Research Center and Department of Internal Medicine, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA展开收起
306
天
ENO1 as a potential tumor prognostic marker promotes the proliferation, invasion, and metastasis of breast cancer cells
作者
Lifang He; Yue Xu; Lu Huang; Lijuan He; Zexiao Chen; Zhaochang Qi; Yukun Cui展开收起
作者单位
Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong 515063, China; Shantou Key Laboratory of Precision Diagnosis and Treatment in Women's Cancer, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong 515063, China; State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, Guangdong 511436, China; Guangzhou Morui Pharmaceutical Technology Co., Ltd., Guangzhou Medical University, Guangzhou, Guangdong 511436, China; Precision Oncology Diagnosis and Treatment Centre of Foshan Fosun Chancheng Hospital, Foshan, Guangdong 528031, China; Outpatient Nursing, Hangzhou West Lake Zhijiang Ophthalmology Hospital, Hangzhou, Zhejiang 310000, China展开收起
560
天
Ginsenoside Rg1 attenuates mitochondrial dysfunction in bleomycin-induced pulmonary fibrosis by inhibiting Nrf2/Sirt3 pathways
作者
Qi Qi; Shihao Wen; Linchao Niu; Ru Zhang; Meili Lu; Jingliang Zhang; Hongxin Wang展开收起
作者单位
Key Laboratory of Cardiovascular and Cerebrovascular Drug Research of Liaoning Province, Jinzhou Medical University, Jinzhou, Liaoning 121000, China; Department of Anesthesiology, Jinzhou Central Hospital, Jinzhou Medical University Graduate Training Base, Jinzhou, Liaoning 121000, China; Internal Medicine-Cardiovascular Department, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, China展开收起
131
天
A candidate PTPN5 frameshift variant in a family with a neurodevelopmental disorder supported by a zebrafish loss-of-function model
作者
Yunlong Meng; Yu Chen; Xingkun Tang; Kangyu Liu; YanLi Ma; Yuanhai Xie; Zilin Zhong; Jianjun Chen展开收起
作者单位
Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Department of Pediatrics, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai 200434, China; Institute of Medical Genetics, Department of Big Data in Health Science, School of Public Health and General Medicine, Tongji University School of Medicine, Tongji University, Shanghai 200331, China展开收起
121
天
Genetic engineering of primary human mesenchymal stromal cells using the CRISPR/Cas9 synergistic activation mediator
作者
M.C. Killer; X. Zhang; T. Adhikary; C. Kasper; A. Neubauer; M. Frech; C. Brendel展开收起
作者单位
Department of Hematology, Oncology and Immunology, Marburg University, Marburg 35041, Germany; Department of Regenerative Medicine, Tongji University, Shanghai 200092, China; Institute of Molecular Biology and Tumor Research, Marburg University, Marburg 35041, Germany; Department for Biotechnology and Food Technology, BOKU University, Vienna 1180, Austria展开收起
176
天
Robust prediction of response to growth hormone therapy by five PBMC-based transcripts
作者
Valerie van Kekem; Irene Victoria Bermúdez-Pérez; Alexandra E. Kulle; Maik Welzel; Nadine Hornig; Gerhard Binder; Matthias Hübenthal; Robert Häsler; Paul-Martin Holterhus展开收起
作者单位
Department of Neurology, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel, Arnold-Heller-Straße 3, Kiel 24105, Germany; Department of Dermatology and Allergy, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel, Arnold-Heller-Straße 3, Kiel 24105, Germany; Department of Pediatrics I, Pediatric Endocrinology and Diabetes, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel, Kiel 24105, Germany; Institute of Clinical Chemistry, UKSH, Kiel/Lübeck 24105, Germany; Private Practice of Pediatrics, Am Ochsenkopf 1, Eckernförde 24340, Germany; Institute of Human Genetics, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel, Kiel 24105, Germany; Pediatric Endocrinology, University Children’s Hospital Tübingen, Tübingen 72076, Germany展开收起
FAQ
Genes & Diseases审稿要多久?
截至2026-11-19,CrushSCI 收录了 Genes & Diseases 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 97 天(Targeting nucleolin-driven cancer stemness suppresses high-risk neuroblastoma in vivo,2026-01-21 收稿,2026-04-28 录用),最慢一篇用了 560 天;平均 242.9 天,中位数 176 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
